Prostacyclin Therapy Before Pulmonary Thromboendarterectomy in Patients With Chronic Thromboembolic Pulmonary Hypertension*
Noritoshi Nagaya(National Cerebral and Cardiovascular Center), Norifumi Nakanishi(National Cerebral and Cardiovascular Center), Noriko Sasaki(National Cerebral and Cardiovascular Center), Shingo Kyotani(National Cerebral and Cardiovascular Center), Motomi Ando(Fujita Health University Hospital), Hitoshi Ogino(Tokyo Medical University Hospital), Fumio Sakamaki(Keio University)
Cited by 213
Related Papers
Plasma Brain Natriuretic Peptide as a Prognostic Indicator in Patients With Primary Pulmonary Hypertension
|Circulation|2000|880
Plasma Brain Natriuretic Peptide Levels Increase in Proportion to the Extent of Right Ventricular Dysfunction in Pulmonary Hypertension
|Journal of the American College of Cardiology|1998|578
Mutations of the TGF-β type II receptorBMPR2 in pulmonary arterial hypertension
|Human Mutation|2006|404
Percutaneous Transluminal Pulmonary Angioplasty for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
|Circulation Cardiovascular Interventions|2012|381
Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension
|Circulation Cardiovascular Quality and Outcomes|2017|336